Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Under the Jazz Collaboration Agreement, as of December 31, 2025 we have received (i) a non-refundable $50.0 million upfront payment following receipt of HSR Clearance and delivery of licenses and technology transfer to Jazz, (ii) a further payment of $325.0 million following Jazz's decision to continue the collaboration after readout of the top-line clinical data from HERIZON-BTC-01, in addition to our delivery of other data, analyses and other information, and (iii) a milestone payment of $25.0 million in relation to FDA approval of Ziihera (zanidatamab-hrii) for the treatment of HER2+ BTC.”
FILING10-K0001937653-26-000015cik 0001937653disclosed by ZYME
“Modeyso is manufactured by Adare, which is a sole source supplier.”
FILING10-K0001232524-26-000013cik 0001232524
“Rylaze drug substance is manufactured by AGC Biologics A/S at its facility in Copenhagen, Denmark and the drug product is manufactured and packaged by Patheon at its facility in Greenville, North Carolina.”
FILING10-K0001232524-26-000013cik 0001232524
“We depend on outside vendors, including ESSDS, the central certified pharmacy, to distribute Xywav and Xyrem in the U.S., provide patient support services and implement the requirements of the Xywav and Xyrem REMS.”
FILING10-K0001232524-26-000013cik 0001232524
“Rylaze drug substance is manufactured by AGC Biologics A/S at its facility in Copenhagen, Denmark and the drug product is manufactured and packaged by Patheon at its facility in Greenville, North Carolina.”
FILING10-K0001232524-26-000013cik 0001232524
“Zepzelca is manufactured by Simtra, which is a sole source supplier from a single site location.”
FILING10-K0001232524-26-000013cik 0001232524
“We currently rely on WuXi (Hong Kong), a company based in the PRC and subsidiary of WuXi, as the sole supplier of Ziihera.”
FILING10-K0001232524-26-000013cik 0001232524
“Our collaborator, Jazz Pharmaceuticals plc (Jazz), sponsored and managed the Phase 1b/2 trial of zanidatamab, a HER2-targeted anti-cancer antibody, for the treatment of advanced HER2-expressing breast cancer and other solid tumors in combination with evorpacept (Zanidatamab Trial).”
FILING10-K0001193125-26-098454cik 0001810182disclosed by ALXO
“In May 2022, the Company acquired the U.S. rights to SUNOSI ® (solriamfetol) from Jazz Pharmaceuticals plc ("Jazz"), and in November 2022, the Company acquired worldwide ex-U.S. rights (excluding certain Asian markets) from Jazz (collectively, the "Acquisition").”
FILING10-K0001193125-26-064267cik 0001579428disclosed by AXSM
“In October 2025, we divested Sativex to CNX Therapeutics, who will assume responsibility for Sativex in all countries it is approved.”
FILING10-K0001232524-26-000013cik 0001232524
“In July 2021, Jazz announced the U.S. launch of Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), previously referred to as JZP458.”
FILING10-K0000886163-26-000006cik 0000886163disclosed by LGND
“• Autifony to collaborate on discovering and developing drug candidates targeting two different ion channel targets associated with neurological disorders;”
FILING10-K0001232524-26-000013cik 0001232524
“We completed the Chimerix Acquisition in April 2025 for a total of cash consideration of $944.2 million, adding Modeyso (dordaviprone), a protease activator of the mitochondrial ClpP that also inhibits DRD2, to our rare oncology portfolio.”
FILING10-K0001232524-26-000013cik 0001232524
“Our exclusive U.S. development and commercialization rights to Zepzelca were acquired through an exclusive license agreement we entered into with PharmaMar in December 2019.”
FILING10-K0001232524-26-000013cik 0001232524
“• Redx for preclinical collaboration activities related to G12D selective and pan-KRAS molecules that we purchased from Redx;”
FILING10-K0001232524-26-000013cik 0001232524
“• Saniona to develop a small molecule activator of Kv7.2/Kv7.3 potassium channels for epilepsy and other potential indications;”
FILING10-K0001232524-26-000013cik 0001232524
“In May 2022, we announced that we had entered into a licensing agreement with Sumitomo to acquire exclusive development and commercialization rights in the U.S., Europe and other territories for JZP441.”
FILING10-K0001232524-26-000013cik 0001232524
“We acquired rights to JZP898 from Werewolf in 2022 under an exclusive, worldwide, royalty-bearing license to develop, manufacture and commercialize Werewolf's investigational WTX-613, now referred to as JZP898.”
FILING10-K0001232524-26-000013cik 0001232524
“• XLp for rights to use XLp's PASylation ® technology to extend the plasma half-life of selected asparaginase product candidates;”
FILING10-K0001232524-26-000013cik 0001232524
“We are also paid for supply of the Hikma AG product and are reimbursed by Hikma for a portion of the services costs associated with the operation of the Xywav and Xyrem REMS, and distribution of the Hikma AG product.”
FILING10-K0001232524-26-000013cik 0001232524
Watchlist prices, news filtered to it, and its next report on your desk.
Jazz Pharmaceuticals plc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 241.60 · gapped above the open, then crossed back over prior close. High/low 247.23 at 9:15 am ET, 240.15 at 3:30 pm ET.
Jazz Pharmaceuticals plc has 16 disclosed suppliers and 4 disclosed customers. Each one is named in an SEC filing, either Jazz Pharmaceuticals plc’s own annual report or the counterparty’s, and carries the sentence that discloses it.
JAZZ (Jazz Pharmaceuticals plc) has 16 disclosed suppliers and 4 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move, and a bundle sits past the rings until you open it. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: LGND +0.76%, in the health bundle.